Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA Technology

2015 ◽  
Vol 126 (5) ◽  
pp. 1095-1099 ◽  
Author(s):  
Yuval Yaron ◽  
Jacques Jani ◽  
Maximilian Schmid ◽  
Dick Oepkes
Keyword(s):  
Current Status ◽  
Cell Free Dna ◽  
Microdeletion Syndromes ◽  
Free Dna ◽  
Dna Technology

Noninvasive Prenatal Testing by Cell-Free DNA: Technology, Biology, Clinical Utility, and Limitations

2019 ◽  
pp. 627-652
Author(s):  
Francesca Romana Grati ◽  
Komal Bajaj ◽  
Giuseppe Simoni ◽  
Federico Maggi ◽  
Susan J. Gross ◽  
...  
Keyword(s):  
Clinical Utility ◽  
Prenatal Testing ◽  
Noninvasive Prenatal Testing ◽  
Cell Free Dna ◽  
Free Dna ◽  
Dna Technology

Cell-free DNA as a post-treatment surveillance strategy: current status

2017 ◽  
Vol 44 (5) ◽  
pp. 330-346 ◽  
Author(s):  
Justin M. Burgener ◽  
Ariana Rostami ◽  
Daniel D. De Carvalho ◽  
Scott V. Bratman
Keyword(s):  
Post Treatment ◽  
Current Status ◽  
Surveillance Strategy ◽  
Cell Free Dna ◽  
Free Dna

False negative fetal cell free DNA screening for microdeletion syndromes in the presence of an unbalanced translocation involving monosomy 4p

2017 ◽  
Vol 37 (4) ◽  
pp. 420-422 ◽  
Author(s):  
Zhongxia Qi ◽  
Shreshtha Madaan ◽  
Shilpa Chetty ◽  
Jingwei Yu ◽  
Arun P. Wiita
Keyword(s):  
False Negative ◽  
Unbalanced Translocation ◽  
Fetal Cell ◽  
Cell Free Dna ◽  
Microdeletion Syndromes ◽  
Free Dna

Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives

2018 ◽  
Vol 55 (1) ◽  
pp. 55-70 ◽  
Author(s):  
Kristina V. Glebova ◽  
Natalya N. Veiko ◽  
Aleksey A. Nikonov ◽  
Lev N. Porokhovnik ◽  
Svetlana V. Kostuyk
Keyword(s):  
Current Status ◽  
Cell Free Dna ◽  
Free Dna

Current status and future perspectives of circulating cell-free DNA methylation in clinical diagnostics

2016 ◽  
Vol 40 (5) ◽  
Author(s):  
Dimo Dietrich
Keyword(s):  
Dna Methylation ◽  
Clinical Diagnostics ◽  
Current Status ◽  
Future Perspectives ◽  
Cell Free Dna ◽  
Bodily Fluids ◽  
Free Dna ◽  
Aberrant Dna Methylation ◽  
Pathologic Processes ◽  
Circulating Cell Free Dna

Abstract:Aberrant DNA methylation is a hallmark of malignancies and can be detected in circulating cell-free DNA (ccfDNA) in bodily fluids, i.e. blood plasma, serum and urine. The availability of technologies that allow for an accurate and sensitive quantification of ccfDNA DNA methylation enables the precise monitoring of dynamic pathologic processes and pharmacodynamics. Recently, the first ccfDNA methylation biomarker

scholarly journals Current Status in Non-Invasive Prenatal Detection of Down Syndrome, Trisomy 18, and Trisomy 13 Using Cell-Free DNA in Maternal Plasma

2013 ◽  
Vol 35 (2) ◽  
pp. 177-181 ◽  
Author(s):  
Sylvie Langlois ◽  
Jo-Ann Brock ◽  
R. Douglas Wilson ◽  
François Audibert ◽  
Jo-Ann Brock ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Maternal Plasma ◽  
Trisomy 18 ◽  
Trisomy 13 ◽  
Current Status ◽  
Cell Free Dna ◽  
Non Invasive ◽  
Prenatal Detection ◽  
Free Dna
Sign in / Sign up

Export Citation Format

Share Document